✦ LIBER ✦

Enhancement of anti-tumor activity of recombinant interleukin-2 (rIL-2) by immunocomplexing with a monoclonal antibody against rIL-2

✍ Scribed by Jun Sato; Naoru Hamaguchi; Kazuhiro Doken; Kazunori Gotoh; Koichiro Ootsu; Susumu Iwasa; Yasuaki Ogawa; Hajime Toguchi

Publisher: Springer
Year: 1993
Tongue: English
Weight: 582 KB
Volume: 6
Category: Article
ISSN: 0921-299X
DOI: 10.1007/bf01878084

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor effects of local irradiation

Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)

✍ I.-M. Jürgenliemk-Schulz; I.B. Renes; D.H. Rutgers; L.A. Everse; M.R. Bernsen; W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB

The aim of this work was to improve radiotherapy results by immune stimulation. We tested the effects of a combination of radio-and immunotherapy, i.e., local low dose recombinant interleukin-2 (rIL-2) treatment, in two murine tumor models. Syngeneic tumors (SL2 lymphoma or M8013 mammary carcinoma)

Enhanced induction of lymphokine-activat

Enhanced induction of lymphokine-activated killer (LAK) cells by combination of human recombinant interleukin 2 (RIL 2) and nocardia rubra cell wall skeleton (N-CWS) in mice

✍ I. Kawase; T. Shirasaka; T. Masuno; S. Kishimoto; Y. Yamamura 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Anti-tumor activity of T-2 toxin-conjuga

Anti-tumor activity of T-2 toxin-conjugated A7 monoclonal antibody (T-2-A7 MoAb) against human colon carcinoma

✍ Dr. Shuji Kojima; Namie Nakamura; Yoshio Ueno; Toshiharu Yamaguchi; Toshio Takah 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 651 KB

Monoclonal antibody A7 047 MoAb), from splenocytes of a mouse immunized against human colorectal carcinoma, was used as a T-2 toxin Cr-2) carrier targeting colon cancer. T-2 was converted to T-2 hemiglutarate by glutaric anhydride treatment, and T-2-A7 MoAb conjugates containing up to 20 T-2 per ant

Prolongation of rat pancreatic islet all

Prolongation of rat pancreatic islet allograft survival by treatment of recipient rats with monoclonal anti-interleukin-2 receptor antibody and cyclosporin

✍ H. J. Hahn; B. Kuttler; A. Dunger; I. Klöting; S. Lucke; H. D. Volk; R. v. Baehr 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 339 KB

Specific antitumor activity of tumor-inf

Specific antitumor activity of tumor-infiltrating lymphocytes expanded first in a culture with both anti-CD3 monoclonal antibody and activated B cells and then in a culture with interleukin-2

✍ Koji Tamada; Mamoru Harada; Tadao Okamoto; Mitsuhiro Takenoyama; Osamu Ito; Goro 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 894 KB

Curing BB rats of freshly manifested dia

Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A

✍ Hans J. Hahn; Silke Lucke; Ingrid Klöting; Hans D. Volk; Rüdiger V. Baehr; Tibor 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB

## Curing BB rats of freshly manifested diabetes by shortterm treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of cyclosporin A The BioBreeding (BB) rat develops spontaneously a syndrome resembling human type I diabetes mellitus. The short